JPRN-jRCT2080222041未知3 期
Phase III clinical trial of L-105 in patients with hepatic encephalopathy
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Subjects of completed the preceding study (L-105/2-A)
排除标准
- •-Grade III or higher hepatic encephalopathy coma level (Coma Level Classification by Inuyama Symposium)
研究者
相似试验
未知
2 期
Phase II/III clinical trial of L-105 in patients with hepatic encephalopathyH.E.JPRN-jRCT2080222040ASKA Pharmaceutical Co., Ltd.180
已完成
2 期
Phase II/III clinical trial of L-105 in pediatric patients with hepatic encephalopathyHepatic encephalopathyJPRN-jRCT2080224978ASKA Pharmaceutical Co., Ltd.20
未知
3 期
X-P Phase 3 Open StudyFrozen shoulder syndrome, Tendinitis/Tenosynovitis, Peritendinitis, Humeral epicondylitis (Tennis elbow, etc.)JPRN-jRCT2080222338EAD CHEMICAL COMPANY, LIMITED264
招募中
1 期
Study of LY3537982 in Cancer Patients with a Specific Genetic Mutation (KRAS G12C)SCLCCRCEndometrial NeoplasmsOvarian NeoplasmsPancreatic NeoplasmsBiliary Tract NeoplasmsFrontline, 1L, First LineJPRN-jRCT2031210265Masaki Takeshi80
未知
3 期
Phase 3 clinical study of RM-003 in patients with homocystinuriaHomocystinuria, described as the following casescystathionine beta-synthase deficiency(CBS), 5,10-methylenetetrahydrofolate reductase deficiency, defects in cobalamin metabolismJPRN-jRCT2080221773ReqMed Company, Ltd.8